Channelopathy as a SUDEP Biomarker in Dravet Syndrome Patient-Derived Cardiac Myocytes

Stem Cell Reports - United States
doi 10.1016/j.stemcr.2018.07.012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Serotonergic Modulation as Effective Treatment for Dravet Syndrome in a Zebrafish Mutant Model

ACS Chemical Neuroscience
BiochemistryMedicinePhysiologyCell BiologyCognitive Neuroscience
2016English

Drug Screening in Scn1a Zebrafish Mutant Identifies Clemizole as a Potential Dravet Syndrome Treatment

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2013English

Pluripotent Stem Cell Models of a Cardiac Sodium Channelopathy

Biophysical Journal
Biophysics
2012English

Unexpected Hemophagocytic Syndrome in a Post-Cardiac Surgery Patient

Critical Care
Critical CareIntensive Care Medicine
2011English

Massive Cardiac Thrombosis in a Patient With Sheehan’s Syndrome

Endocrine Journal
EndocrinologyMetabolismDiabetes
2005English

Perineal Stimulation Triggering Seizures in a Child With Dravet Syndrome

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2018English

Irregular Respiratory Rhythm: A Physiological Biomarker of SUDEP Risk in Patients With Nocturnal Seizures?

Epilepsy Currents
Neurology
2016English

Circulating Tumor Cells as a Biomarker of Response to Treatment in Patient Derived Xenograft Mouse Models of Pancreatic Adenocarcinoma

Journal of the American College of Surgeons
Surgery
2013English

Heart Rate Variability as a Biomarker of Fibromyalgia Syndrome

Future Rheumatology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy